Search PubMed⌕ Search

Biomedical subjects

E Haug

Publications and source records attributed to E Haug.

At least 55 records · Page 3Linked to original sources
PubMed1998

Vitamin D deficiency in pregnancy is not associated with obstructed labor. A study among Pakistani women in Karachi.

BACKGROUND: Vitamin D deficiency is widespread among pregnant Pakistanis in Norway. It may cause osteomalacia with destruction of maternal pelvis, and thus be a risk factor for cephalopelvic disproportion. This study was performed to determine whether vitamin D deficiency is common among pregnant Pakistanis in Pakistan, and to test the hypothesis that vitamin D deficiency in nulliparous pregnant women is associated with mechanical dystocia. METHODS: The study was carried out at the Civil Hospital, in a poor area of Karachi, and had a case-referent design. Thirty-seven nulliparous parturients with Cesarean section due to mechanical dystocia served as cases, and 80 nulliparous parturients with uncomplicated vaginal delivery were their referents. All blood samples were drawn before parturition. RESULTS: The mothers with obstructed labor were shorter (on average 150 vs. 155 cm, p= 0.0001) and lighter (on average 58 vs. 60.5 kg, p=0.005) than their referents. Seventy-one percent (83/117) of all the participants had marginal or low vitamin D status defined as serum level of calcidiol (25-OH vitamin D3) below 30 nmol/l. Vitamin D deficiency was, however, not more widespread among the mothers with obstructed labor (20/37 vs. 63/80). Furthermore, there were no significant differences in the serum levels of the carboxyterminal telopeptide of type I collagen, a sensitive biochemical marker of bone resorption, (7.2 vs. 6.6 microg/l), and bone specific alkaline phosphate (18.1 vs. 22.0 U/l) a sensitive marker of bone formation. CONCLUSIONS: Vitamin D deficiency in pregnancy is common in Karachi, but is not associated with mechanical dystocia.

Adult↗
PubMed1997

Blood sampling in doping control. First experiences from regular testing in athletics.

We report the results from blood sampling taken for the first time during doping control in athletics. The study includes samples from 99 athletes tested during IAAF-meetings in 1993-94. Blood doping with allogenic blood was not detected. The distribution of haemoglobin levels in athletes did not differ markedly from that found in controls. Erythropoietin (EPO) values were markedly lower in athletes than in controls, and 58% had EPO lower than the detection limit for the assay. This may be due to high-altitude residence prior to testing. Measurements of growth hormone (GH) and insulin-like growth factor 1 did not suggest GH-misuse in any athlete tested. One third of the male athletes had testosterone levels that were lower than the normal reference interval. This may at least partly be due to the combination of sampling at night and after strenuous exercise. One female athlete was found to have a grossly elevated testosterone level. In conclusion, the present results show the importance of taking into account the special circumstances during sampling when interpreting results from blood testing in athletes. Future research should focus on developing more sensitive and specific tests to detect doping with endogenous substances such as GH and EPO.

Bilirubin↗
PubMed1997

Serum N-terminal pro-atrial natriuretic factor 1-98 before and during thyroxine replacement therapy in severe hypothyroidism.

Decreased plasma concentrations of atrial natriuretic factor (ANF) and of its N-terminal prohormones have been demonstrated in severely hypothyroid patients compared with control subjects, and shown to normalize with thyroxine (T4) replacement therapy. Whether this depends on thyroid hormone deficiency exclusively or is secondary to hemodynamic changes that result from it remains a matter of debate. In a recent investigation dose-related increases in both ANF and N-terminal prohormones of ANF by T4 replacement therapy in incremental doses increased at 4-week intervals were demonstrated. It was suggested that thyroid hormones may enhance synthesis rather than release of atrial peptide hormones. The aim of the present study was to confirm this assumption in hypothyroid patients with normal cardiac performance. Serum N-terminal amino acids 1-98 (ie, pro-ANF 1-98) of pro-ANF was determined in 11 severely hypothyroid patients without pericardial effusion and with normal cardiac left ventricular function. Mean pro-ANF 1-98 concentration before T4 replacement therapy remained unchanged after 10 days on T4 (p = .12). After 2 months of therapy, mean pro-ANF 1-98 was significantly increased compared with pretreatment values (p < .003). A significant correlation to the increase in free T4 (r = 0.48, p < .01) but not to the decrease in thyrotropin (TSH) (r = -0.32, p = .09) was found. The present results indicate that thyroid hormones directly increase pro-ANF 1-98 independently of cardiac hemodynamics in the hypothyroid state.

Adult↗
PubMed1997

Effect of intensive training on lower leg structural strength: an in vivo study in ovariectomized rats.

The aim of this study was to investigate the effect of training on the in vivo tibial structural strength during the development of post-ovariectomy osteoporosis. Seventeen mature Wistar rats (215 g) were ovariectomized and randomized into two groups. The sedentary control group was kept cage confined, while 3 days postoperatively the trained group started treadmill running with high intensity for 1 h 5 days a week. All were given a low calcium diet (Ca 0.01%). After 8 weeks the animals were anaesthetized and the right lower legs fractured during muscle contraction in three-point ventral bending. The left legs were fractured at the same level after removal of all soft tissues. Histomorphometry of the meta- and diaphysis of the distal tibiae was performed. Weight-gain was higher in sedentary (108 g) than in trained (61 g) rats (P<0.0001). There were no significant differences in mechanical results between the groups at in vivo or in vitro fracture. Correcting for weight-gain differences did not change these results. Histomorphometry showed no differences between the groups. Corticosterone was higher in trained than in sedentary rats (P<0.02), and corticosterone may have had a negative influence both on muscle and bone. The study could not show an effect of high intensity training in the early phase after ovariectomy on in vivo or in vitro fracture strength.

Animals↗
PubMed1997

Elevated levels of sex hormones and sex hormone binding globulin in male patients with insulin dependent diabetes mellitus. Effect of improved blood glucose regulation.

In a prospective study we have measured serum levels of sex hormone-binding globulin (SHBG), androgens, oestrogens and gonadotropins in 20 male IDDM patients with the aim of evaluating the effect of improved glycaemic control on these levels and to compare the IDDM patients with an age- and weight-matched healthy non-diabetic control group. The patients were chosen from the male IDDM patients attending the outpatient clinic at the Department of Endocrinology, Odense University Hospital. Glycaemic control was optimized by a trained diabetologist according to the patients' measurements of home blood glucose concentrations and reported hypoglycaemic episodes during a three month period. Prior to regulation the patients, compared to healthy control subjects, had significantly higher serum levels of oestrone (0.29 +/- 0.02 vs 0.16 +/- 0.01 nmol/l (Mean +/- SEM), p < 0.01), 17 beta-oestradiol (0.12 +/- 0.01 vs 0.08 +/- 0.01 nmol/l, p < 0.01), dihydrotestosterone (4.20 +/- 0.18 vs 1.66 +/- 0.09 nmol/l, p < 0.01), total testosterone (20.7 +/- 0.9 vs 17.8 +/- 1.1 nmol/l, p < 0.05) and SHBG (42.3 +/- 2.9 vs 15.5 +/- 3.5 nmol/l, p < 0.05), while the calculated free-testosterone was lower (0.34 +/- 0.02 vs 0.40 +/- 0.02 nmol/l, p = 0.068). After regulation, the patients obtained significantly lower levels of glycosylated haemoglobin (10.4 +/- 0.3 vs 8.9 +/- 0.2%, p < 0.005) and serum fructosamine (1.50 +/- 0.05 vs 1.34 +/- 0.04 nmol/l, p < 0.005) on a higher 24 hour insulin dose (52.7 +/- 4.4 vs 59.2 +/- 4.6 IU/24 h, p < 0.005). Levels of free-testosterone (0.41 +/- 0.04 nmol/l), oestrone (0.33 +/- 0.03 nmol/l), oestradiol (0.14 +/- 0.01 nmol/l), delta 4-androstenedione (4.44 +/- 0.43 vs 3.85 +/- 0.42 nmol/l), and prolactin (249 +/- 24 vs 200 +/- 19 mIU/l) increased compared to values obtained before regulation (all p < 0.05). We conclude that SHBG, testosterone, dihydrotestosterone and oestrogen levels are increased in male IDDM patients. High SHBG levels tend to keep the free fractions of sex hormones within normal limits. During improvement of glycaemic control with insulin, levels of free-testosterone and its bioprecursors and metabolites rise. This may partly be due to the increased daily insulin dose and/or to the improvement in glycaemic control itself.

Adult↗
PubMed1996

Vitamin D deficiency and fetal growth.

Vitamin D deficiency in pregnancy has been associated with decreased fetal growth, but previous studies have found no direct relation between the weight of the new-born child and the maternal serum level of 25-hydroxyvitamin D3 (calcidiol). The aim of this study was to evaluate the relation between maternal serum calcium and parathyroid hormone with reduced fetal growth in vitamin D deficient pregnant women. Thirty Pakistani women were included in the study at delivery. Only mothers without known chronic diseases who delivered vaginally after an uncomplicated pregnancy were included. Anthropometric data were recorded, and blood samples were drawn from the mothers 1-4 h after delivery. Nearly all (29/30) the Pakistani women had low (< 30 nmol/l) serum levels of 25-hydroxyvitamin D3. Thirteen of the mothers had high serum parathyroid hormone (PTH) levels (> 5.5 pmol/l). The median (range) level of ionised calcium in serum was 1.23 (1.15-1.28) nmol/l. A positive correlation was found between the level of ionised calcium in maternal serum and the crown-heel length of the infant (Spearman's rho = 0.65, P = 0.002, n = 20). The maternal serum PTH was related inversely to the crown-heel length (Spearman's rho = -0.47, P = 0.01, n = 30). No confounding effect of gestational age, sex of the infant, maternal height and body mass index (BMI) was found. The study indicates that vitamin D deficiency affects fetal growth through an effect on maternal calcium homeostasis.

Calcifediol↗
PubMed1996

[Vitamin D deficiency among pregnant women from Pakistan. How best to prevent it?].

Vitamin D deficiency is common among pregnant Pakistani women now living in Norway. This study was carried out to evaluate a health programme consisting of free samples of vitamin D (10 micrograms/day) combined with information about vitamin D deficiency. 38 pregnant women were included in the 18th week of pregnancy (study group) and blood samples were taken both at inclusion and after delivery. In addition, 18 other Pakistani women (control group) were included after giving birth at the same hospitals during the same period. 83% (30/36) of the pregnant women (study group) were vitamin D deficient (calcidiol < 30 nmol/l) at inclusion. Only 33% (11/33) of the women took more vitamin D than 5 micrograms/day. 19 of the women agreed to having a new blood sample taken after delivery, and 56% (10/18) of these women were still vitamin D deficient. 76% (13/17) of the women in the control group were vitamin D deficient at delivery. In conclusion the study demonstrates that it can be difficult to prevent vitamin D deficiency in the Norwegian immigrant population just by providing information and free samples of vitamin D.

Adult↗
PubMed1996

Serum calcidiol and calcitriol concentrations in elderly people: variations with age, sex, season and disease.

The influence of age, sex, seasonal variations and vitamin D supplementation on serum concentrations (s-conc.) of calcidiol and calcitriol were studied in 311 hospitalized and 106 home-living people aged 70 years and over, residing at 60 degrees latitude. The serum calcidiol conc. (mean + SD, nmol/L) was reduced in the hospital group compared to the home-living group (males: 40.6 +/- 23.2 compared to 59.6 +/- 28.9; females: 37.3 +/- 22.6 compared to 48.5 +/- 20.3) and showed no seasonal variation. The home-living group showed highest levels in August-September (62.2 +/- 26), and lowest levels in January-March (42.9 +/- 21). Serum calcidiol declined with age, most prominent in the home group (males: r = -0.13, P = 0.036;females: r = -0.33, P = 0.001). A positive correlation was shown between s-calcitriol and s-calcidiol conc. (r = 0.26, P > 0.001). An increased s-conc. of calcidol was present in those with vitamin supplementation (home: 59.9 +/- 26; hospital: 43.4 +/- 22) compared to those without supplementation (home: 46.6 +/- 22; hospital: 36.2 +/- 22), but s-calcidiol conc. did not correlate to nutritional vitamin D intake. Vitamin D deficiency (s-calcidiol conc. < 30 nmol/L) was more common in old people recently admitted to hospital, compared to those living at home. Only the home-living group had the benefit of sunlight exposure, but both groups may benefit from vitamin supplementation.

Journal Article↗
PubMed1996

Fracture rate, pre- and postmenopausal bone mass and early and late postmenopausal bone loss are not associated with vitamin D receptor genotype in a high-endemic area of osteoporosis.

To investigate a possible association between vitamin D receptor genotype and development of postmenopausal osteoporosis, a longitudinal study from 1977 to 1995 was carried out on women living in Oslo, Norway. One hundred and eighteen premenopausal women born in 1930 were included in a study of pre- and postmenopausal bone loss in 1977. In 1995, blood samples for vitamin D receptor genotyping were available in 72, 42 and 49 of the women eligible for the determination of premenopausal bone mineral content, early postmenopausal appendicular bone loss and late postmenopausal bone mineral content, bone loss and fractures, respectively. Bone mineral density was measured in the distal and proximal right forearm annually from 1977 to 1987, and in the lumbar spine, proximal femur, right forearm and total body, including ultrasound measurements of the right calcaneus, in 1993 and 1995. Non-spinal fractures were also recorded. The results were compared to the individual vitamin D receptor genotype and it was found that vitamin D receptor genotype was neither associated with non-spinal fractures, pre- and post-menopausal bone mass nor with early and late postmenopausal bone loss within the age of 65 years. In conclusion, premenopausal bone mass, postmenopausal bone loss and the subsequent risk of osteoporosis and fractures were not predicted by vitamin D receptor genotype in a high-endemic area of osteoporosis.

Aged↗
PubMed1996

Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia.

Hormonal changes resulting from long-term use of the luteinizing hormone-releasing hormone agonist leuprolide depot were studied in a randomized placebo-controlled study comprising 50 evaluable patients with benign prostatic hyperplasia (BPH). A total of 26 patients received 3.75 mg leuprolide depot intramuscularly every 28 days for 24 weeks and 24 received a placebo. The patients were followed up for a further 24-week period. Serum concentrations of luteinizing hormone decreased by 90% and follicle-stimulating hormone by 55% during the treatment period. Mean testosterone levels decreased by 96% to 0.7 nmol l-1 and dihydrotestosterone decreased by 90%. The adrenal androgens androstenedione and dehydroepiandrosterone sulphate decreased by 48 and 24%, respectively. In most patients, estradiol decreased to non-detectable values, while the decrease in estrone was 35%. There was no change in prolactin and sex hormone-binding globulin as compared to the placebo group. Hormonal changes were reversible, but the suppression of testicular hormone production was not completely normalized in all patients 24 weeks after discontinuation of the treatment.

Aged↗
PubMed1996

Training increases the in vivo fracture strength in osteoporotic bone. Protection by muscle contraction examined in rat tibiae.

The effect of high-intensity training on the in vivo lower leg fracture strength during muscle contraction was investigated in osteoporotic rats. 20 Wistar rats were ovariectomized and given a low calcium (0.01%) diet. 7 weeks after ovariectomy they were randomized into training (T) and sedentary (S). The S group was kept cage-confined without any intervention. The T group ran on a treadmill with 10 degrees inclination 5/7 days for 8 weeks. A maximum intensity of 27 m/min was reached after 4 weeks. After 8 weeks, the right lower legs of the anesthetized animals were loaded in three-point ventral bending until fracture occurred during electrically-induced muscle contraction. The left tibiae were excised and fractured at the same level as the right tibiae. Weight gain was equal in the two groups. Energy absorption and deflection at fracture were significantly higher in the T group than in the S group in vivo during muscle contraction. In vitro, there were no significant differences in mechanical results. The mediolateral outer diameter was larger in the T group, and the maximal stress that the tibia could withstand was lower than in the S group. We conclude that 8 weeks of high-intensity training of osteoporotic rats increased the structural lower leg strength during muscle contraction. The reduced maximal stress in the training animals indicates a reduction in bone material quality. The increase of in vivo structural strength must reflect an increased protective effect of muscle contraction due to training.

Animals↗
PubMed1995

[Osteoporosis drugs prescribed on blue forms!].

The National Insurance Administration, through the system of blue prescription forms, refunds part of the cost of drugs used to treat a number of chronic diseases. To obtain a refund, the indication for prescribing the drug must be included in the list of diagnoses which entitle a refund through the system. The list is a long one, and costs are refunded for prophylactic drugs (e.g. against hypertension and hypercholesterolemia), drugs to alleviate symptoms (e.g. for certain skin diseases and heart failure) and curative measures. The qualitative criteria for a refund, over and above the diagnosis, are not precisely defined, and doctors are free to choose the drug they prefer, regardless of price. The authors discuss whether the list of diagnoses should be extended to include osteoporosis, and recommend that doctors should be able to prescribe the relevant preventive and palliative drugs on a blue form. Many think that this refund system is a good initiative.

Aged↗
PubMed1995

Thyroid function in seasonal affective disorder.

Morning serum levels of triiodothyronine (T3), free thyroxine (F-T4) and thyroid-stimulating hormone (TSH) were measured in Winter-Seasonal Affective Disorder patients in nondepressed state in summer and before and after light treatment in winter. Practically all patients had hormone levels well within the reference ranges. T3 and F-T4, but not TSH, were significantly higher in winter than in summer; this is considered a normal phenomenon. There was no significant correlation between hormone levels and severity of winter depression. Light treatment did not alter serum hormone levels.

Adult↗
PubMed1995

Incidence of hypertrophic cardiomyopathy in hypothyroidism.

In 13 consecutive severely hypothyroid patients no sign of endocrine cardiomyopathy in the form of asymmetric septal hypertrophy (ASH) could be disclosed by M-mode and two-dimensional (2D) echocardiography on examination prior to thyroxine replacement therapy. In previous investigations ASH was demonstrated to be almost invariably present in untreated hypothyroidism irrespective of thyrotropin levels. Consequently application of positive inotropic and afterload reducing agents that may invoke deleterious effects in ASH has been considered hazardous in hypothyroidism even when indicated by concurrent other heart disease. Determination of exact confidence limits reveals that the proportional incidence of hypothyroid hypertrophic cardiomyopathy could not exceed 24.7% with 95% probability. We conclude that ASH is not necessarily inherent in hypothyroidism.

Adult↗
PubMed1995

Silent myocardial ischemia in hypothyroidism.

In some patients with severe hypothyroidism thyroxine replacement therapy precipitates or aggravates angina pectoris, whereas in other patients angina pectoris is ameliorated or even disappears. The reason for this paradox is unknown. It has been attributed either to reversible endocrine cardiomyopathy in the form of asymmetric septal hypertrophy (ASH) or reversible anatomical narrowing of the coronary arteries. The results of a recent investigation, in which myocardial performance was surveyed by radionuclide ventriculography throughout early thyroxine replacement therapy in severe hypothyroidism, were compatible with the presence of reversible coronary dysfunction rather than of ASH. The aim of the present investigation was to confirm these findings. In six severely hypothyroid patients, without echocardiographic evidence of ASH or evidence of concomitant coronary artery disease (CAD), exercise and redistribution tomographic myocardial thallium-201 imaging (SPECT) was performed before thyroxine replacement therapy and repeated after 10 days and again after 2 months during therapy. In four patients substantial regional perfusion defects were demonstrated after exercise that were normalized at rest both before, and in one subject also after 10 days, on thyroxine. With restoration of euthyroidism, exercise and redistribution SPECT were normal in every patient. Determination of exact confidence limits reveals that the proportional incidence of myocardial perfusion defects in hypothyroidism, indicating myocardial ischemia, will at least be 22% with 95% probability. Despite the relatively low specificity of SPECT it seems pertinent to conclude that impaired myocardial perfusion as assessed by SPECT probably is due to reversible coronary dysfunction inherent in the hypothyroid state, and that this is not an infrequent manifestation of severe hypothyroidism.

Adult↗
PubMed1995

Somatostatin in physiological concentrations inhibits basal and enhances luteinizing hormone-stimulated progesterone release from human granulosa-luteal cells.

To study the effect of somatostatin on ovarian function, we investigated the action of physiological concentrations of somatostatin (5.0 x 10(-12)-1.0 x 10(-10) M) on the basal and luteinizing hormone (LH)-stimulated progesterone release from cultured human granulosa-luteal cells obtained from in-vitro fertilization patients. Somatostatin exerted a significant and inhibitory effect on basal progesterone release from the granulosa-luteal cells, whereas it was unable to inhibit LH-stimulated progesterone release. Instead, a significant increase in progesterone release was observed after concomitant incubation with LH and somatostatin compared with the untreated controls. We suggest that somatostatin may serve as a regulator of ovarian functions under physiological conditions.

Basal Metabolism↗